UPDATE 1-Drugmaker Regeneron beats profit estimates on Eylea sales
August 06, 2019 at 07:06 AM EDT
Regeneron Pharmaceuticals Inc beat analysts' estimates for second-quarter profit and revenue on Tuesday, boosted by demand for its blockbuster eye treatment Eylea and eczema drug Dupixent.
